SEC Comment Letter 0000000000-24-012484 to MAINZ BIOMED N.V. (MYNZ) (CIK 0001874252) (MYNZ)
MAINZ BIOMED N.V. (MYNZ) (CIK 0001874252)
Date: Nov. 8, 2024 · CIK: 0001874252 · Accession: 0000000000-24-012484
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282993
Letter
November 8, 2024 William Caragol Chief Financial Officer Mainz Biomed N.V. Robert Koch Strasse 50 55129 Mainz Germany Re:Mainz Biomed N.V. Registration Statement on Form F-1 Filed November 5, 2024 File No. 333-282993 Dear William Caragol: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Tim Dockery
Show Raw Text
November 8, 2024
William Caragol
Chief Financial Officer
Mainz Biomed N.V.
Robert Koch Strasse 50
55129 Mainz
Germany
Re:Mainz Biomed N.V.
Registration Statement on Form F-1
Filed November 5, 2024
File No. 333-282993
Dear William Caragol:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Tim Dockery